Results 121 to 130 of about 86,213 (145)

Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies. [PDF]

Eur J Haematol
Röth A, Fu R, He G, Alzahrani H, Chou SC, Hicheri Y, Kaźmierczak M, Recova VL, Uchiyama M, Vladareanu AM, Beveridge L, Buatois S, Buri M, Compagno N, Shi D, Balachandran N, Sreckovic S, Scheinberg P.   +17 more
europepmc   +1 more source

Invited letter MUC4 mutations as an amplifier of complement‐mediated thrombosis in paroxysmal nocturnal haemoglobinuria

Clinical and Translational Discovery
Eng Soo Yap, Edwin Wei Sheng Thong, Cheryl Xiu Qi Lim   +2 more
doaj   +1 more source

Coombs-positive Paroxysmal Nocturnal Haemoglobinuria [PDF]

Oxford Medical Case Reports, 2020
Autoimmune haemolytic anaemia (AIHA) and paroxysmal nocturnal haemoglobinuria (PNH) are two distinct causes of haemolytic anaemia. They have different mechanisms that underpin their pathogenesis and, therefore, require different treatment strategies. The
Umasuthan Srirangalingam, Rupert Beale, Austin Kulasekararaj   +2 more
exaly   +2 more sources